The McKesson Corporation and CVS Health Extend Their Pharmaceutical Distribution Agreement


Through June 2027, McKesson Corporation and CVS Health will continue to work together to supply medications to retail pharmacies, mail-order and specialty pharmacies, and distribution centres. This was announced today by McKesson Corporation.

“We are pleased to continue our long-standing relationship with CVS Health and value the shared commitment of improving health outcomes for all patients”, “We are privileged to extend our partnership of more than 20 years to continue developing value propositions for patients utilizing our diverse set of differentiated assets and capabilities.”

Brian Tyler, chief executive officer, McKesson

Additionally, on Tuesday, November 1, 2022, after market close, McKesson announce its financial results for the second quarter of fiscal 2023. At 4:30 PM Eastern Time, the company will offer a live webcast of its earnings conference call for investors to discuss its financial performance.

Next Post

TechTarget Launches Prospect-Level Purchase Intent Data for Healthcare in Latest Release of its Priority Engine Platform

TechTarget, Inc., the industry pioneer in prospect-level intent data and services for B2B technology purchases, today announced the launch of Priority EngineTM for Healthcare to assist sales and marketing teams in utilising their prospect-level intent data to generate more opportunities and pipeline with leading organisations in the healthcare sector. In […]